paid-only post Nov 11, 2025 activistcompany BML Capital condemns Adverum Biotechnologies, Inc (ADVM) merger with Eli Lilly as flawed and value-destructive This post is for paying subscribers only Subscribe to continue reading Subscribe now Already have an account? Sign in
More Provident Reaches Board Agreement, Withdraws Proxy Contest at ZIM Integrated Shipping Services Ltd (ZIM) 01 Jan